Response to: "Consideration of KRAS Mutation Status May Enhance the Prognostic Impact of Indeterminate Extrahepatic Disease in the Lungs, as Identified by 18FDG-PET, in Patients With Colorectal Liver Metastases"

Ann Surg. 2018 Jul;268(1):e9-e10. doi: 10.1097/SLA.0000000000002266.

¹ Department of Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia. Department of Medical Oncology, Flinders Cancer for Innovation in Cancer, Adelaide, South Australia, Australia Department of Surgery, Flinders Medical Centre, Adelaide, South Australia, Australia South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia Department of Surgery, Flinders Medical Centre & Flinders University, Adelaide, South Australia, Australia Department of Medical Oncology, Flinders Medical Centre & Flinders University, Adelaide, South Australia, Australia Department of Medical Oncology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia Department of Surgery, Flinders Medical Centre & Flinders University, Adelaide, South Australia, Australia.

No abstract available

Publication types